Charles Schwab Investment Management Inc Ideaya Biosciences, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $527 Billion
  • Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 712,811 shares of IDYA stock, worth $16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
712,811
Previous 689,073 3.44%
Holding current value
$16 Million
Previous $21.8 Million 16.08%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
BUY
$24.79 - $31.98 $588,465 - $759,141
23,738 Added 3.44%
712,811 $18.3 Million
Q3 2024

Nov 12, 2024
BUY
$30.37 - $43.05 $2.38 Million - $3.38 Million
78,518 Added 12.86%
689,073 $21.8 Million
Q2 2024

Aug 12, 2024
BUY
$34.37 - $43.46 $1.41 Million - $1.78 Million
40,966 Added 7.19%
610,555 $21.4 Million
Q1 2024

May 08, 2024
BUY
$34.2 - $47.13 $2.5 Million - $3.45 Million
73,133 Added 14.73%
569,589 $25 Million
Q4 2023

Feb 06, 2024
BUY
$24.59 - $35.83 $1.45 Million - $2.12 Million
59,100 Added 13.51%
496,456 $17.7 Million
Q3 2023

Nov 08, 2023
BUY
$21.07 - $29.77 $6.14 Million - $8.67 Million
291,240 Added 199.32%
437,356 $11.8 Million
Q2 2023

Aug 09, 2023
BUY
$13.33 - $25.53 $358,750 - $687,088
26,913 Added 22.58%
146,116 $3.43 Million
Q1 2023

May 11, 2023
BUY
$13.49 - $18.72 $14,366 - $19,936
1,065 Added 0.9%
119,203 $1.64 Million
Q4 2022

Feb 13, 2023
BUY
$14.47 - $18.17 $382,499 - $480,305
26,434 Added 28.83%
118,138 $2.15 Million
Q3 2022

Nov 14, 2022
BUY
$9.24 - $15.79 $8,177 - $13,974
885 Added 0.97%
91,704 $1.37 Million
Q2 2022

Aug 15, 2022
BUY
$8.28 - $13.88 $43,445 - $72,828
5,247 Added 6.13%
90,819 $1.25 Million
Q1 2022

May 13, 2022
BUY
$11.18 - $24.02 $23,578 - $50,658
2,109 Added 2.53%
85,572 $958,000
Q4 2021

Feb 11, 2022
BUY
$20.95 - $26.88 $5,824 - $7,472
278 Added 0.33%
83,463 $1.97 Million
Q3 2021

Nov 16, 2021
BUY
$17.26 - $27.08 $302,895 - $475,226
17,549 Added 26.74%
83,185 $2.12 Million
Q2 2021

Aug 16, 2021
BUY
$17.76 - $24.83 $387,416 - $541,641
21,814 Added 49.78%
65,636 $1.38 Million
Q1 2021

May 17, 2021
BUY
$13.48 - $23.77 $62,196 - $109,674
4,614 Added 11.77%
43,822 $1.03 Million
Q3 2020

Nov 13, 2020
BUY
$11.22 - $14.46 $149,057 - $192,101
13,285 Added 51.25%
39,208 $493,000
Q2 2020

Aug 14, 2020
BUY
$3.59 - $18.57 $93,063 - $481,390
25,923 New
25,923 $369,000

Others Institutions Holding IDYA

# of Institutions
217
Shares Held
81.2M
Call Options Held
69K
Put Options Held
20K
View Full List

About IDEAYA Biosciences, Inc.

IDYA Quotes by TradingView
  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.08B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email